Engineeringthe Next
Standard of Care
Triple Helix Science is an institutional-grade biotechnology company built for governments, institutions, and enterprise partnerships.
A NEW ERA AGAINST CANCER, DEMENTIA, AND AGING WITH GENES
Our Divisions
Core Operating Divisions of Triple Helix Science
Triple Helix Corporate
Partnering with sovereign governments, hospitals, medical schools, and research institutes for manufacturing & clinical translation.
Triple Helix Medicine
Clinical partner delivering 17+ medical specialty divisions, advanced gene/cell therapies, and physician referral pathways.
Triple Helix Veterinary
Bringing human gene and cellular medical science to companion animals across Mexico City, Dubai, and Abu Dhabi.
Triple Helix Lifestyle
Precision longevity, cellular rejuvenation protocols, and performance bio-optimization therapeutics.
Triple Helix Compassion
Our sister charity BioHelix NP providing life-saving gene and cell therapies to patients in need globally.
Environmental Science
Gene-therapy heat-resistant coral, ocean acidification mitigation, and solar-powered fresh water chemistry.
Science Platforms & Global Footprint
Proprietary platforms, gmp-grade manufacturing, and sovereign infrastructure
Triple Helix Medicine: 17 Clinical Specialty Divisions
Comprehensive translational care across dedicated clinical departments
Top Divisions
Interventional Oncology – Neuro – Vascular
Explore Specialty ↗
Internal Medicine – Gene Therapy
Explore Specialty ↗
Cardiothoracic Surgery & Vascular Translation
Explore Specialty ↗
Psychiatry & Neurology
Explore Specialty ↗
Dr. Patrick E Sewell MD
“The genome is not a mystery to be solved — it is an instruction set to be read.”
Our work is translation: from genetic sequence to clinical outcome, with the precision that institutional medicine demands. Dr. Sewell brings an exceptional track record in regenerative medicine with extensive IP-protected research programs development, founding Triple Helix Science with a sovereign-partnership focus under his direct leadership.
Planned Clinical Trials Pipeline (2026 / 2027)
Multi-jurisdictional research and translational medicine targeting critical unmet needs
Alzheimer's & Dementia
Phase 1 dementia progression reversal protocols and neurodegenerative arrest trials.
Sarcopenia & Muscle
Targeted myotropic gene therapies restoring muscle protein synthesis and mobility.
Thymus Regeneration
Restoring immune competence, T-cell maturation, and systemic longevity in aging cohorts.
Sensory & Autoimmune
Inherited blindness, sensorineural hearing loss, and refractory autoimmune modulation.
Connect with Triple Helix Science
Patient consultation requests, physician referral with secure record upload, and sovereign institutional partnership inquiries.